Regulatory News
Monday, January 23, 2017
BRIEF-Kamada announces positive scientific advice response from the European Medicines Agency
* Kamada announces positive scientific advice response from
the European Medicines Agency focused on Alpha-1 antitrypsin IV
for treatment of acute graft-versus-host disease
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment